Mycobacterium bovis bacillus Calmette-Guérin therapy is a potent immunostimulator for management of systemic malignancies

Clinical and Vaccine Immunology

Volumn 15, Issue 8, 2008, Pages 1307-

  Kapoor, Shailendra ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CELECOXIB; RETINOBLASTOMA PROTEIN;

BCG VACCINATION; BLADDER CANCER; CANCER IMMUNOTHERAPY; CYSTECTOMY; HUMAN; INTERSTITIAL CYSTITIS; LETTER; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

BCG VACCINE; CYSTITIS, INTERSTITIAL; HUMANS; MYCOBACTERIUM BOVIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 49149116008     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00052-08     Document Type: Letter

References (7)

1. Aghamir, S. M., M. G. Mohseni, and S. Arasteh. 2007. Intravesical bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. Urol. J. 4:18-23.
2. Chen, F., G. Zhang, Y. Cao, R. Payne, and W. A. See. 2007. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury. J. Urol. 178:2166-2170.
3. Demkow, T., A. Alter, and P. Wiechno. 2008. Intravesical bacillus Calmette-Guerin therapy for T1 superficial bladder cancer. Urol. Int. 80:74-79.
4. Dovedi, S. J., J. A. Kirby, B. R. Davies, H. Leung, and J. D. Kelly. 2008. Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma. Eur. Urol. doi:10.1016/j.eururo.2008.01.013. [Epub ahead of print.]
5. Esuvaranathan, K., E. Chiong, T. P. Thamboo, Y. H. Chan, R. Kamaraj, R. Mahendran, and M. Teh. 2007. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer 109:1097-1105.
6. Mendez-Samperio, P., A. Trejo, and A. Perez. 2008. Mycobacterium bovis bacillus Calmette-Guérin induces CCL5 secretion via the Toll-like receptor 2-NF-κB and -Jun N-terminal kinase signaling pathways. Clin. Vaccine Immunol. 15:277-283.
7. Shintani, Y., Y. Sawada, T. Inagaki, Y. Kohjimoto, Y. Uekado, and T. Shinka. 2007. Intravesical instillation therapy with bacillus Calmette-Guerin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guerin immunotherapy. Int. J. Urol. 14:140-146.